Gilbert J Burckart (Gilbert Burckart)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 38

Top Topics

Bariatric Surgery

Chronic Myeloid Leukemia

Drug Administration

Top Venues

Journal of clinical pharmacology

Clinical pharmacology and therapeutics

Children (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Zachary L Taylor, Francis G Green, Nayeem Hossain, Gilbert J Burckart, Michael Pacanowski, Robert N Schuck
Assessment of Dosing Strategies for Pediatric Drug Products. Clinical pharmacology and therapeutics 116 (3) (2024)
Zachary L Taylor, Francis G Green, Nayeem Hossain, Gilbert J Burckart, Michael Pacanowski, Robert N Schuck
Assessment of Dosing Strategies for Pediatric Drug Products. Clinical pharmacology and therapeutics (2024)
Zachary L Taylor, Francis G Green, Nayeem Hossain, Gilbert J Burckart, Michael Pacanowski, Robert N Schuck
Assessment of Dosing Strategies for Pediatric Drug Products. Clinical pharmacology and therapeutics (2024)
Susan M Abdel-Rahman, Andrew J Farrell, N Seth Berry, Gilbert J Burckart
Optimizing Dosage in Pharmacotherapy-Missing the Forest for the Trees. Clinical pharmacology and therapeutics (2024)
Xiaomei I Liu, Dionna J Green, John van den Anker, Joaquin Calderon, Homa Ahmadzia, Gilbert J Burckart, André Dallmann
Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. Journal of clinical pharmacology (2024)
Zachary L Taylor, Francis G Green, Nayeem Hossain, Gilbert J Burckart, Michael Pacanowski, Robert N Schuck
Assessment of Dosing Strategies for Pediatric Drug Products. Clinical pharmacology and therapeutics 116 (3) (2024)
Kayla R Tunehag, Blessy A George, Sherbet Samuels, Karen Vo, Vikram Arya, Gelareh Abulwerdi, Gilbert J Burckart
Food-Drug Effects and Pediatric Drug Development Studies Submitted to the US Food and Drug Administration, 2012-2022. Journal of clinical pharmacology (2024)
Susan M Abdel-Rahman, Andrew J Farrell, N Seth Berry, Gilbert J Burckart
Optimizing Dosage in Pharmacotherapy-Missing the Forest for the Trees. Clinical pharmacology and therapeutics 116 (3) (2024)
Zachary L Taylor, Francis G Green, Nayeem Hossain, Gilbert J Burckart, Michael Pacanowski, Robert N Schuck
Assessment of Dosing Strategies for Pediatric Drug Products. Clinical pharmacology and therapeutics 116 (3) (2024)
Kayla R Tunehag, Blessy A George, Sherbet Samuels, Karen Vo, Vikram Arya, Gelareh Abulwerdi, Gilbert J Burckart
Food-Drug Effects and Pediatric Drug Development Studies Submitted to the US Food and Drug Administration, 2012-2022. Journal of clinical pharmacology 64 (6) (2024)
Xiaomei I Liu, Dionna J Green, John van den Anker, Joaquin Calderon, Homa Ahmadzia, Gilbert J Burckart, André Dallmann
Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. Journal of clinical pharmacology (2024)
Brianna Eales, Nada A Helal, Olivia Vattelana, Mohamad M Kronfol, Elimika Pfuma Fletcher, Yow-Ming C Wang, Gilbert J Burckart, Jayabharathi Vaidyanathan, Shirley K Seo, Mohamed Ismail Nounou
Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products. Journal of clinical pharmacology (2024)
Jayabharathi Vaidyanathan, Elimika Pfuma Fletcher, Anuradha Ramamoorthy, Rajanikanth Madabushi, Gilbert J Burckart
Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities. Journal of clinical pharmacology (2023)
Sherbet Samuels, Jane P F Bai, Dionna J Green, Gelareh Abulwerdi, Gilbert J Burckart
Application of Quantitative Systems Pharmacology to Pediatric Drug Safety Assessment. Clinical pharmacology and therapeutics (2023)
Gelareh Abulwerdi, Gilbert J Burckart, Milap C Nahata, Hanna Phan
In Memoriam: Varsha Bhatt-Mehta, PharmD, MS, FCCP. Journal of clinical pharmacology (2023)
Gelareh Abulwerdi, Gilbert J Burckart, Milap C Nahata, Hanna Phan
In Memoriam: Varsha Bhatt-Mehta, PharmD, MS, FCCP. Journal of clinical pharmacology (2023)
Sherbet Samuels, Jayabharathi Vaidyanathan, Elimika Pfuma Fletcher, Anuradha Ramamoorthy, Rajanikanth Madabushi, Gilbert J Burckart
Need for Representation of Pediatric Patients with Obesity in Clinical Trials. Children (Basel, Switzerland) 10 (10) (2023)
Sherbet Samuels, Varsha Bhatt-Mehta, Kyunghun Park, Gilbert J Burckart
Obesity Considerations in Pediatric Drug Development, 2016-2021. Journal of clinical pharmacology (2023)
Xiaomei I Liu, Ruby Leong, Gilbert J Burckart, André Dallmann
Physiologically-based pharmacokinetic modeling of nilotinib for drug-drug interactions, pediatric patients, and pregnancy and lactation. Journal of clinical pharmacology (2023)
Gilbert J Burckart, David J Greenblatt
Addressing the Knowledge Gaps for Providing Optimal Drug Pharmacotherapy for the Obese. Journal of clinical pharmacology (2023)
Gelareh Abulwerdi, Gilbert J Burckart, Milap C Nahata, Hanna Phan
In Memoriam: Varsha Bhatt-Mehta, PharmD, MS, FCCP. Journal of clinical pharmacology (2023)
William C Zamboni, Rosane Charlab, Gilbert J Burckart, Clinton F Stewart
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer Agents. Journal of clinical pharmacology (2023)
Gelareh Abulwerdi, Gilbert J Burckart, Milap C Nahata, Hanna Phan
In Memoriam: Varsha Bhatt-Mehta, PharmD, MS, FCCP. Journal of clinical pharmacology (2023)
Daphne Guinn, Marilyn Gafford, Gilbert J Burckart, Gregory Reaman, Rosane Charlab
Assessing Information Gaps Associated with Initial Pediatric Study Plans for New Oncology Drug and Biological Products. Clinical pharmacology and therapeutics (2023)
Clara Kim, Kyunghun Park, Ann W McMahon, Francis G Green, Dionna J Green, Gilbert J Burckart
Drug Safety in Labeling for Pediatric Drug Development and Dose Selection in Submissions to the US Food and Drug Administration. Journal of clinical pharmacology (2022)
Rosane Charlab, Gilbert J Burckart, Gregory H Reaman
Fine-Tuning the Relevance of Molecular Targets to Pediatric Cancer: Addressing Additional Layers of Complexity. Clinical pharmacology and therapeutics (2022)
Xiaomei I Liu, John N van den Anker, Gilbert J Burckart, André Dallmann
Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups. Journal of clinical pharmacology (2022)
Kyunghun Park, Ngan K Tran, Jeremiah D Momper, Dionna J Green, Gilbert J Burckart
Pediatric and Adult Placebo Response Rates in Placebo-Controlled Clinical Trials Submitted to the US Food and Drug Administration 2012-2020. Journal of clinical pharmacology 62 (8) (2022)
Francis G Green, Kyunghun Park, Gilbert J Burckart
Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020. Journal of clinical pharmacology (2022)
Gilbert J Burckart, John van den Anker, André Dallmann
Fetal Clinical Pharmacology: A New Frontier of Drug Safety and Therapeutics. Journal of clinical pharmacology (2022)
Sherbet Samuels, Kyunghun Park, Varsha Bhatt-Mehta, Haihao Sun, Yeruk Mulugeta, Lynne Yao, Dionna J Green, Gilbert J Burckart
Pediatric Efficacy Extrapolation in Drug Development Submitted to the US Food and Drug Administration 2015-2020. Journal of clinical pharmacology (2022)
Jian Wang, John N van den Anker, Gilbert J Burckart
Progress in Drug Development-Pediatric Dose Selection: Workshop Summary. Journal of clinical pharmacology (2022)
Gilbert J Burckart, John N van den Anker
Neonatal and Pediatric Dose Selection: Quo Vadis? Journal of clinical pharmacology (2022)
Qunshu Zhang, James Travis, Rebecca Rothwell, Christopher E Jay, Rashid Jahidur, Yifei Zhang, Victor Crentsil, Tara Altepeter, Jessica J Lee, Gilbert J Burckart, Charles Ganley, Jian Wang
Applying the Noninferiority Paradigm to Assess Exposure-Response Similarity and Dose Between Pediatric and Adult Patients. Journal of clinical pharmacology (2022)
Qi Liu, Janice B Schwartz, Patricia W Slattum, S W Johnny Lau, Daphne Guinn, Rajanikanth Madabushi, Gilbert J Burckart, Robert M Califf, Francesca Cerreta, Carolyn Cho, Jack Cook, Jamie Gamerman, Paul Goldsmith, Piet H van der Graaf, Jerry H Gurwitz, Sebastian Haertter, Sarah Nicole Hilmer, Shiew Mei Huang, Sharon K Inouye, Bindu Kanapuru, Munir Pirmohamed, Phil Posner, Barbara Radziszewska, H Keipp Talbot, Robert Temple
Roadmap to 2030 for Drug Evaluation in Older Adults. Clinical pharmacology and therapeutics (2021)
Jeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, Donna Griebel, Shaun Kumar, Insook Kim, Nitin Mehrotra, Andrew E Mulberg, Narayana Garimella, Robert Nelson, Gregory Reaman, Vikram Sinha, Lynne Yao, Issam Zineh, Gilbert J Burckart, Hari Sachs, Yeruk Mulugeta
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and Vomiting. Journal of clinical pharmacology 60 (6) (2020)
Amer Al-Khouja, Kyunghun Park, Daijha J C Anderson, Caitlyn Young, Jian Wang, Shiew Mei Huang, Mona Khurana, Gilbert J Burckart
Dosing Recommendations for Pediatric Patients With Renal Impairment. Journal of clinical pharmacology 60 (12) (2020)
Luning Zhuang, Jianmeng Chen, Jingyu Yu, Anshu Marathe, Chandra Sahajwalla, Mark Borigini, Janet Maynard, Gilbert J Burckart, Yaning Wang
Dosage Considerations for Canakinumab in Children With Periodic Fever Syndromes. Clinical pharmacology and therapeutics 106 (3) (2019)